• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Serum sickness-like reaction in a pediatric patient using omalizumab for chronic spontaneous urticaria.

作者信息

Eapen Amy, Kloepfer Kirsten M

机构信息

Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Division of Pulmonary, Department of Pediatrics, Allergy and Sleep Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.

出版信息

Pediatr Allergy Immunol. 2018 Jun;29(4):449-450. doi: 10.1111/pai.12877. Epub 2018 Apr 15.

DOI:10.1111/pai.12877
PMID:29444344
Abstract
摘要

相似文献

1
Serum sickness-like reaction in a pediatric patient using omalizumab for chronic spontaneous urticaria.一名使用奥马珠单抗治疗慢性自发性荨麻疹的儿科患者出现血清病样反应。
Pediatr Allergy Immunol. 2018 Jun;29(4):449-450. doi: 10.1111/pai.12877. Epub 2018 Apr 15.
2
Omalizumab-induced triphasic anaphylaxis in a patient with chronic spontaneous urticaria.奥马珠单抗诱发慢性自发性荨麻疹患者的三相过敏反应。
J Eur Acad Dermatol Venereol. 2016 Nov;30(11):e135-e136. doi: 10.1111/jdv.13439. Epub 2015 Oct 7.
3
A Case of Serum Sickness-Like Reaction in an Adult Treated with Omalizumab.奥马珠单抗治疗成人后发生血清病样反应 1 例
Mil Med. 2020 Jun 8;185(5-6):e912-e913. doi: 10.1093/milmed/usz357.
4
Development of angio-oedema after omalizumab injections in a patient with chronic spontaneous urticaria.一名慢性自发性荨麻疹患者在注射奥马珠单抗后发生血管性水肿。
Clin Exp Dermatol. 2018 Oct;43(7):825. doi: 10.1111/ced.13616. Epub 2018 May 18.
5
Effectiveness and safety of omalizumab in a patient with chronic urticaria and hepatitis C.奥马珠单抗在一名慢性荨麻疹合并丙型肝炎患者中的有效性和安全性。
J Eur Acad Dermatol Venereol. 2015 May;29(5):1027-8. doi: 10.1111/jdv.12450. Epub 2014 Mar 14.
6
Efficacy of omalizumab in severe chronic spontaneous urticaria: Real life data from a Greek tertiary center.奥马珠单抗治疗重度慢性自发性荨麻疹的疗效：来自希腊一家三级中心的真实数据。
Dermatol Ther. 2018 Nov;31(6):e12739. doi: 10.1111/dth.12739. Epub 2018 Nov 5.
7
Efficacy of Omalizumab Treatment with Concomitant Antihistamines as Needed for Moderate, Refractory Chronic Spontaneous Urticaria.奥马珠单抗治疗联合按需使用抗组胺药治疗中度难治性慢性自发性荨麻疹的疗效
Acta Derm Venereol. 2018 Apr 16;98(4):446-448. doi: 10.2340/00015555-2886.
8
Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study.奥马珠单抗治疗慢性自发性荨麻疹的疗效评估：一项前瞻性研究。
J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1761-1767. doi: 10.1111/jdv.15045. Epub 2018 May 29.
9
Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety.奥马珠单抗治疗慢性自发性荨麻疹：疗效与安全性专家综述
Expert Opin Biol Ther. 2017 Mar;17(3):375-385. doi: 10.1080/14712598.2017.1285903. Epub 2017 Feb 9.
10
Omalizumab in chronic spontaneous and inducible urticaria: a 9 year retrospective study in Portugal.奥马珠单抗治疗慢性自发性和诱导性荨麻疹：葡萄牙一项为期9年的回顾性研究。
Eur Ann Allergy Clin Immunol. 2018 Jul;50(4):169-176. doi: 10.23822/EurAnnACI.1764-1489.51. Epub 2018 Jan 16.

引用本文的文献

1
Hypersensitivity reactions to biologics used in the treatment of allergic diseases: clinical features, diagnosis and management.用于治疗过敏性疾病的生物制剂的超敏反应：临床特征、诊断与管理
Front Allergy. 2023 Aug 11;4:1219735. doi: 10.3389/falgy.2023.1219735. eCollection 2023.
2
Risks and safety of biologics: A practical guide for allergists.生物制剂的风险与安全性：过敏症专科医生实用指南。
World Allergy Organ J. 2023 Jan 16;16(1):100737. doi: 10.1016/j.waojou.2022.100737. eCollection 2023 Jan.
3
Therapeutical Targets in Allergic Inflammation.
过敏性炎症的治疗靶点
Biomedicines. 2022 Nov 9;10(11):2874. doi: 10.3390/biomedicines10112874.
4
Hypersensitivity and Immune-related Adverse Events in Biologic Therapy.生物治疗中的过敏反应和免疫相关不良事件。
Clin Rev Allergy Immunol. 2022 Jun;62(3):413-431. doi: 10.1007/s12016-021-08879-w. Epub 2021 Jul 28.
5
Adrenal insufficiency is a contraindication for omalizumab therapy in mast cell activation disease: risk for serum sickness.肾上腺功能不全是肥大细胞活化疾病中奥马珠单抗治疗的禁忌证：有血清病风险。
Naunyn Schmiedebergs Arch Pharmacol. 2020 Sep;393(9):1573-1580. doi: 10.1007/s00210-020-01886-2. Epub 2020 May 6.
6
Highlights and recent developments in skin allergy and related diseases in EAACI journals (2018).欧洲变态反应与临床免疫学会（EAACI）期刊中皮肤过敏及相关疾病的亮点与近期进展（2018年）
Clin Transl Allergy. 2019 Nov 20;9:60. doi: 10.1186/s13601-019-0299-y. eCollection 2019.